Author: Dr.S.Harsha Vardhan

Posted on

COVID-19 : Managing Liver Dysfunction During The Pandemic

Patients with COVID-19 may develop abnormal liver function and it’s important to consider the potential impact of COVID-19 on the liver, especially in the Asia-Pacific region where chronic liver diseases are prevalent, say the authors of a position statement.

The statement, from the Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic, provides 36 recommendations covering the use of drug therapy for COVID-19 in the case of liver dysfunction, and assessment and management of patients with chronic hepatitis B or hepatitis C, non-alcoholic fatty liver disease, liver cirrhosis, and liver transplantation.

Continue reading
Posted on

Minimally Invasive Surgery & Risk of Capsule Rupture for Women With Early-Stage Ovarian Cancer

Ovarian cancer remains the deadliest gynecologic malignant neoplasm in the United States. Salpingo-oophorectomy with the intact removal of the ovary and fallopian tube is the standard approach for suspected ovarian malignant neoplasm apparently confined to the ovary. Surgery for early-stage ovarian cancer has historically been performed via laparotomy. However, in recent years, more women with ovarian cysts and masses have been treated with minimally invasive surgery (MIS), including laparoscopy. To date, there are limited data to support the safety and oncologic outcomes of MIS for early-stage ovarian cancer. The objective of this study was to examine the association between MIS use, capsule rupture, and survival of women with stage I epithelial ovarian cancer.

 
Continue reading